arrow
P

Piotr J. Wysocki

jagiellonian university-medical college
H指数:27
被引数:2,709

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A randomised, open-label, phase II study of tobemstomig combinations in patients with previously untreated advanced clear-cell renal cell carcinoma

一项关于托贝莫司替组合在先前未经治疗的晚期透明细胞肾细胞癌患者中的随机、开放标签II期研究

2026-10-090
OAAI
First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial

一线durvalumab联合曲妥珠单抗deruxtecan治疗局部晚期不可切除或转移性,激素受体阴性,HER2-low乳腺癌的女性: 多中心,开放标签,1b/2期海棠平台试验

2026-06-080
OAAI
Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice
2024-01-230
OAAI
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03 interim results of a randomised, active-controlled, observer-blinded, phase 3 trial

以AS03为佐剂的SARS-CoV-2重组蛋白纳米颗粒疫苗GBP510的免疫原性和安全性随机,主动对照,观察者盲,3期试验的中期结果

2023-10-0115
OAAI